1-4 of 4
Peter F. Mühlradt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Mucosal Adjuvant Macrophage-Activating Lipopeptide-2 Directly Stimulates B Lymphocytes via the TLR2 without the Need of Accessory Cells

Stefan Borsutzky, Karsten Kretschmer, Pablo D. Becker, Peter F. Mühlradt, Carsten J. Kirschning, Siegfried Weiss, Carlos A. Guzmán
Journal: The Journal of Immunology
J Immunol (2005) 174 (10): 6308–6313.
https://doi.org/10.4049/jimmunol.174.10.6308
Published: 15 May 2005
View articletitled, The Mucosal Adjuvant Macrophage-Activating Lipopeptide-2 Directly Stimulates B Lymphocytes via the TLR2 without the Need of Accessory Cells
Open the PDF for The Mucosal Adjuvant Macrophage-Activating Lipopeptide-2 Directly Stimulates B Lymphocytes via the TLR2 without the Need of Accessory Cells in another window
Add to Citation Manager for The Mucosal Adjuvant Macrophage-Activating Lipopeptide-2 Directly Stimulates B Lymphocytes via the TLR2 without the Need of Accessory Cells
Journal Articles

Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes

Taro Kawai, Osamu Takeuchi, Takashi Fujita, Jun-ichiro Inoue, Peter F. Mühlradt, Shintaro Sato, Katsuaki Hoshino, Shizuo Akira
Journal: The Journal of Immunology
J Immunol (2001) 167 (10): 5887–5894.
https://doi.org/10.4049/jimmunol.167.10.5887
Published: 15 November 2001
View articletitled, Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes
Open the PDF for Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes in another window
Add to Citation Manager for Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes
Journal Articles

Synergy and Cross-Tolerance Between Toll-Like Receptor (TLR) 2- and TLR4-Mediated Signaling Pathways

Shintaro Sato, Fumiko Nomura, Taro Kawai, Osamu Takeuchi, Peter F. Mühlradt, Kiyoshi Takeda, Shizuo Akira
Journal: The Journal of Immunology
J Immunol (2000) 165 (12): 7096–7101.
https://doi.org/10.4049/jimmunol.165.12.7096
Published: 15 December 2000
View articletitled, Synergy and Cross-Tolerance Between Toll-Like Receptor (TLR) 2- and TLR4-Mediated Signaling Pathways
Open the PDF for Synergy and Cross-Tolerance Between Toll-Like Receptor (TLR) 2- and TLR4-Mediated Signaling Pathways in another window
Add to Citation Manager for Synergy and Cross-Tolerance Between Toll-Like Receptor (TLR) 2- and TLR4-Mediated Signaling Pathways
Journal Articles

Cutting Edge: Preferentially the R-Stereoisomer of the Mycoplasmal Lipopeptide Macrophage-Activating Lipopeptide-2 Activates Immune Cells Through a Toll-Like Receptor 2- and MyD88-Dependent Signaling Pathway

Osamu Takeuchi, Andreas Kaufmann, Karsten Grote, Taro Kawai, Katsuaki Hoshino, Michael Morr, Peter F. Mühlradt, Shizuo Akira
Journal: The Journal of Immunology
J Immunol (2000) 164 (2): 554–557.
https://doi.org/10.4049/jimmunol.164.2.554
Published: 15 January 2000
View articletitled, Cutting Edge: Preferentially the R-Stereoisomer of the Mycoplasmal Lipopeptide Macrophage-Activating Lipopeptide-2 Activates Immune Cells Through a Toll-Like Receptor 2- and MyD88-Dependent Signaling Pathway
Open the PDF for Cutting Edge: Preferentially the R-Stereoisomer of the Mycoplasmal Lipopeptide Macrophage-Activating Lipopeptide-2 Activates Immune Cells Through a Toll-Like Receptor 2- and MyD88-Dependent Signaling Pathway in another window
Add to Citation Manager for Cutting Edge: Preferentially the R-Stereoisomer of the Mycoplasmal Lipopeptide Macrophage-Activating Lipopeptide-2 Activates Immune Cells Through a Toll-Like Receptor 2- and MyD88-Dependent Signaling Pathway